Drug Name Diflucan

Thirty-five years later, about 20 different congeners are being marketed in different countries. This questionable development unfortunately is typical of any drug group that has major therapeutic relevance, in addition to a relatively fixed active structure. Variation of the molecule will create a new patentable chemical, not necessarily a drug with a novel action.
Erythropoiesis is stimulated by the hormone erythropoietin (a glycoprotein), which is released from the kidneys when renal O2 tension declines. Given an adequate production of erythropoietin, a disturbance of erythropoiesis is due to two principal causes: 1. Cell multiplication is inhibited because DNA synthesis is insufficient.

 

When too many ATPases are blocked, K+ and Na+ homeostasis is deranged; the membrane potential falls, arrhythmias occur. Flooding with Ca2+ prevents relaxation during diastole, resulting in contracture. The CNS effects of CG (C) are also due to binding to Na+/K+-ATPases. Enhanced vagal nerve activity causes a decrease in sinoatrial beating rate and velocity of atrioventricular conduction.
The same considerations hold for acidic molecules, with the important difference that alkalinization of the urine (increased pH) will promote the deprotonization of -COOH groups and thus impede reabsorption. Intentional alteration in urinary pH can be used in intoxications with proton-acceptor substances in order to hasten elimination of the toxin.